Jeffrey C Goh Clinical Oncology Society of Australia Annual Scientific Meeting 2018

Abstracts this author is presenting:

• ATHENA (GOG-3020/ENGOT-ov45): a randomised, double-blind, placebo-controlled, phase 3 study of rucaparib + nivolumab following front-line platinum-based chemotherapy in ovarian cancer — Poster Session 2